Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma

Figure 5

The risk score in different groups divided by clinical factors. TCGA cohort (a–d) and ICGC cohort (e, f): (a) age; (b) gender; (c) grade; (d) clinical stage; (e–g) age, gender, and clinical stage.

(a)

(b)

(c)

(d)

(e)

(f)

(g)